Medical Devices Startups
6,088 companies tagged Medical Devices, with their investors and founders.
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems. The technology serves physicians performing thrombectomy procedures for clot management.
2 investors
Dia Beta Labs is a drug discovery and development company focused on diabetes and obesity research. The company leverages academic expertise and scientific innovation in these therapeutic areas.
2 investors
Diag-Nose.io develops precision diagnostics and therapies for respiratory diseases including asthma, COPD, and sinusitis by combining nasal microsampling, proteomics, and machine learning to analyze airway biology. The company serves respiratory specialists, biotech companies, pharmaceutical firms, and researchers.
2 investors
DIANA Biotechnologies is a Czech biotech company that sells products and services to the life sciences research market through a distributed network of regional distributors and scientific marketplaces.
2 investors
Digital Surgery offers the Touch Surgery ecosystem, an AI-powered platform for recording, accessing, and analyzing surgical video in a secure cloud-based library to support post-operative review and performance assessment. It serves surgeons and OR teams and includes a free app of surgical scenarios across multiple specialties for training and preparation.
2 investors
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
2 investors
Dignify Therapeutics develops "on demand" drugs that trigger emptying of the bladder and/or bowel when a person chooses, aimed at restoring control of bowel and bladder function. It operates in the biotechnology and pharmaceutical space focused on therapeutics for people with impaired bladder and bowel control.
2 investors
Ditch Labs develops a medical device and digital health program designed to help individuals quit smoking. The company combines a handheld device (DitchPen) with a companion app and behavioral support to address nicotine addiction.
2 investors
DIVE-Medical develops eye tracking and artificial intelligence technology for objective visual function assessment in children and non-verbal patients. The system detects refractive disorders, amblyopia, strabismus, and other ocular pathologies from six months of age across clinical examination and screening applications.
2 investors
DME Express is a durable medical equipment supplier offering products such as hospital beds, mattresses, oxygen and respiratory equipment, wheelchairs, mobility aids, bariatric equipment, bathroom safety items, and patient lifts. It operates 60+ warehouse locations across multiple US states.
2 investors
Dopl develops a software platform that enables specialists to remotely operate medical devices, beginning with telerobotic ultrasound to deliver diagnostic care to underserved communities. The company targets healthcare access disparities through remote robotic and autonomous care delivery.
2 investors
Dreamfold engineers proteins as therapeutic medicines, using generative AI models that reason over protein sequence and structure to enable potent, localized immune modulation with minimal off-target effects.
2 investors
Droplet Biosciences develops cancer diagnostics with a focus on liquid biopsy and precision oncology. The company works in the molecular diagnostics space for cancer detection and personalized medicine.
2 investors
Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
2 investors
DYNEX Technologies develops and manufactures automated ELISA and chemiluminescence microplate instruments for clinical and diagnostic laboratories. The company serves the global diagnostic and healthcare markets with U.S.-manufactured, ISO-certified diagnostic automation systems.
2 investors
EarlySight develops high-resolution retinal imaging technology combined with AI-driven analysis for early detection of retinal diseases. The company operates in ophthalmology with a focus on revealing abnormalities not visible through standard diagnostic methods.
2 investors
Ebenbuild develops personalized, predictive digital twins for patients with severe illness, using computational models grounded in physics, physiology, biochemistry, and disease mechanisms. The company applies this digital twin technology to healthcare and life sciences to support more individualized and efficient patient care.
2 investors
EchoPixel is a healthcare technology company developing advanced visualization tools to support patient care in the operating room. Founded in 2012, it works with clinical partners to bring new capabilities to medical procedures.
2 investors
Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology. The company works in the medical device space for cardiovascular care.
2 investors
Eclipse Orthopaedics is developing the Radioscopic Targeting Attachment (RTA), a freehand targeting and drilling device to help surgeons perform distal locking during intramedullary nail fixation of leg and hip fractures with less operative time and reduced radiation exposure. The device is aimed at general surgeons in community hospitals and works with existing nail systems and surgical techniques; it is currently under development and not approved for use in humans.
2 investors
Eco-Inject manufactures sustainable single-use autoinjectors for pharmaceutical applications, using a novel design that reduces component count and carbon emissions while maintaining cost parity with conventional devices. The product addresses pharmaceutical companies' environmental commitments and the growing market for home-based self-injection solutions.
2 investors
Lantern is a specialty care platform that connects members with top-rated local providers for surgery, cancer treatment, and infusion therapy, negotiating rates 55% lower than traditional insurance to make care affordable. The company serves employers and their insured members across the United States.
2 investors
Editas Medicine develops gene editing medicines using CRISPR/Cas9 and CRISPR/Cas12a technology to treat serious diseases including blood disorders, cardiovascular conditions, and cancer. The company focuses on in vivo genome editing approaches and serves patients worldwide with transformative, precision genomic medicines.
2 investors
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures. Its products serve hospital surgical and cath lab staff, aiming to meet enhanced radiation protection standards.
2 investors